E-LIB Suche - Ergebnisse für: Makharadze, Tamta

1

A global phase 3 study of serplulimab plus chemotherapy as ..:

Zhou, Caicun ; Hu, Yanping ; Arkania, Ekaterine...
Cancer Cell. 42 (2024) 2 - p. 198-208.e3 , 2024

Link: https://doi.org/10.1016/..

2

Cemiplimab plus chemotherapy versus chemotherapy alone in n..:

Baramidze, Ana ; Makharadze, Tamta ; Gogishvili, Miranda...
Lung Cancer. 193 (2024) - p. 107821 , 2024

Link: https://doi.org/10.1016/..

3

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in A..:

Makharadze, Tamta ; Gogishvili, Miranda ; Melkadze, Tamar...
Journal of Thoracic Oncology. 18 (2023) 6 - p. 755-768 , 2023

Link: https://doi.org/10.1016/..

4

Quality of life with cemiplimab plus chemotherapy for first..:

Makharadze, Tamta ; Quek, Ruben G. W. ; Melkadze, Tamar...
Cancer. 129 (2023) 14 - p. 2256-2265 , 2023

Link: https://doi.org/10.1002/..

5

Response to Letter to the Editor:

Makharadze, Tamta ; Gogishvili, Miranda ; Baramidze, Ana...
Journal of Thoracic Oncology. 18 (2023) 7 - p. e74-e75 , 2023

Link: https://doi.org/10.1016/..

6

Cemiplimab plus chemotherapy versus chemotherapy alone in n..:

Gogishvili, Miranda ; Melkadze, Tamar ; Makharadze, Tamta...
Nature Medicine. 28 (2022) 11 - p. 2374-2380 , 2022

Link: https://doi.org/10.1038/..

7

Cabozantinib plus atezolizumab versus sorafenib for advance..:

Kelley, Robin Kate ; Rimassa, Lorenza ; Cheng, Ann-Lii...
The Lancet Oncology. 23 (2022) 8 - p. 995-1008 , 2022

Link: https://doi.org/10.1016/..

8

Candidate Bevacizumab Biosimilar CT-P16 versus European Uni..:

Verschraegen, Claire ; Andric, Zoran ; Moiseenko, Fedor...
BioDrugs. 36 (2022) 6 - p. 749-760 , 2022

Link: https://doi.org/10.1007/..

9

Randomized phase 3 study of the anti-disialoganglioside ant..:

Edelman, Martin J. ; Dvorkin, Mikhail ; Laktionov, Konstatin...
Lung Cancer. 166 (2022) - p. 135-142 , 2022

Link: https://doi.org/10.1016/..

10

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Bi..:

Trukhin, Dmytro ; Poddubskaya, Elena ; Andric, Zoran...
BioDrugs. 35 (2021) 4 - p. 429-444 , 2021

Link: https://doi.org/10.1007/..

11

Efficacy and safety of ferric carboxymaltose infusion in re..:

Makharadze, Tamta ; Boccia, Ralph ; Krupa, Anna...
American Journal of Hematology. 96 (2021) 12 - p. 1639-1646 , 2021

Link: https://doi.org/10.1002/..

12

Cemiplimab monotherapy for first-line treatment of advanced..:

Sezer, Ahmet ; Kilickap, Saadettin ; Gümüş, Mahmut...
The Lancet. 397 (2021) 10274 - p. 592-604 , 2021

Link: https://doi.org/10.1016/..

13

Candidate Bevacizumab Biosimilar CT-P16 versus European Uni..:

Verschraegen, Claire ; Andric, Zoran ; Moiseenko, Fedor...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649513/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Effect of First-Line Serplulimab vs Placebo Added to Chemot..:

Cheng, Ying ; Han, Liang ; Wu, Lin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516323/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Cabozantinib plus atezolizumab versus sorafenib for advance..:

Kelley, Robin Kate ; Rimassa, Lorenza ; Cheng, Ann Lii...
uri/info:doi/10.1016/S1470-2045(22)00326-6. , 2022

Link: http://hdl.handle.net/20..